Literature DB >> 34492673

Hypoglycemic and lipid lowering effects of theaflavins in high-fat diet-induced obese mice.

Xiaqiang Cai1,2, Zenghui Liu3, Xu Dong1,2, Ying Wang1,2, Luwei Zhu1,2, Mengli Li1,2, Yan Xu1,2.   

Abstract

Theaflavins (TFs) are the characteristic components of black tea and have been widely acknowledged for their health benefits. The current study aimed to investigate the effects and mechanism of TFs, TF1, TF2a and TF3 on glycolipid metabolism in obese mice induced by a high-fat diet (HFD). Mice were randomly divided into seven groups (n = 8 per group) as follows: low-fat diet (LFD), HFD, HFD + metformin (Met, 100 mg kg-1 d-1), HFD + TFs (TFs, 200 mg kg-1 d-1), HFD + TF1 (TF1, 100 mg kg-1 d-1), HFD + TF2a (TF2a, 100 mg kg-1 d-1), and HFD + TF3 (TF3, 100 mg kg-1 d-1). All groups were studied for 9 weeks continuously. The levels of serum glucose, insulin, TC, TG, LDL and HLD in the plasma, lipid accumulation in the liver, and injury of the liver were investigated. In addition, the effects of TFs and their monomers on the SIRT6/AMPK/SREBP-1/FASN pathway were also evaluated. The results showed that oral administration of TFs, TF1, TF2a and TF3 not only dramatically suppressed weight gain, reduced blood glucose level, and ameliorated insulin resistance but also obviously lowered the levels of serum TC, TG and LDL, suppressed the activities of ALT and AST, and ameliorated hepatic damage in mice fed a HFD when compared to the HFD group. Western blot analysis showed that TFs, TF1, TF2a and TF3 treatments increased the expression of SIRT6 and suppressed the expression levels of SREBP-1 and FASN significantly in mice fed a HFD as compared to the HFD group. The phosphorylation of AMPK in mice fed a HFD was obviously elevated by TF2a and TF3 when compared to the HFD group. These results proved for the first time that TF1, TF2a and TF3 improved the glucolipid metabolism of mice fed a HFD, and activated the SIRT6/AMPK/SREBP-1/FASN signaling pathway to inhibit the synthesis and accumulation of lipids in the liver to ameliorate obesity in mice fed a HFD. These findings indicate that TFs, TF1, TF2a and TF3 as the main functional components of black tea might potentially be used as a food additive for improving glycolipid metabolism and ameliorating obesity, and TF3 may be the best choice.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34492673     DOI: 10.1039/d1fo01966j

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  4 in total

1.  Large Yellow Tea Extract Ameliorates Metabolic Syndrome by Suppressing Lipogenesis through SIRT6/SREBP1 Pathway and Modulating Microbiota in Leptin Receptor Knockout Rats.

Authors:  Guohuo Wu; Xiaoyun Sun; Huijun Cheng; Shan Xu; Daxiang Li; Zhongwen Xie
Journal:  Foods       Date:  2022-06-01

2.  Untargeted Metabolomics Combined with Bioassay Reveals the Change in Critical Bioactive Compounds during the Processing of Qingzhuan Tea.

Authors:  Peng-Cheng Zheng; Chun-Yin Qin; Pan-Pan Liu; Lin Feng; Tie-Jun Ling; Jing-Ming Ning; Liang Zhang; Xiao-Chun Wan
Journal:  Molecules       Date:  2021-11-06       Impact factor: 4.411

Review 3.  Beneficial Effects of Theaflavins on Metabolic Syndrome: From Molecular Evidence to Gut Microbiome.

Authors:  Meng Shi; Yuting Lu; Junling Wu; Zhibing Zheng; Chenghao Lv; Jianhui Ye; Si Qin; Chaoxi Zeng
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

4.  Effect of theaflavin-3,3'-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota.

Authors:  Cheng Zhou; Wenji Zhang; Hui Lin; Luyun Zhang; Fan Wu; Yan Wang; Susu Yu; Xinyue Peng; Wenli Cheng; Min Li; Xiaoying Pan; Zhenrui Huang; Wenjuan Zhang
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.